Red-line Drugs Neuro IV Flashcards
Chlorpromazine
Typical antipsychotic D2 antagonist
low potency
Schizophrenia (+ symp.) psychosis, acute mania, Tourette syndrome
Side effects: ANS (dry mouth), sedation, hypotension
Haloperidol
Typical antipsychotics D2 antagonist
High potency
Schizophrenia (+ symp.), Huntington’s
Side effects: EPS tardive dyskinesia Neuroleptic malignant syndrome
Clozapine
Atypical antipsychotics
D2/5HT2A antagonist (low ratio)
Schizophrenia (- symp)
SE: weight gain, *agranulocytosis*, seizures, prolonged QT
Quetiapine
Atypical antipsychotics
D2/5HT2A antagonist (low ratio)
Schizophrenia: (- symp)
SE: weight gain, prolonged QT, some sedation
Paroxetine
SSRI Block SERT
SE: sedation, constipation, weight gain, dry mouth, serotonin syndrome, SIADH, sexual dysfunction, withdrawal symptoms
Escitralopram
SSRI Block SERT
SE: fewest of the SSRIs
Bupropion
NE DA reuptake inhibitor (NDRI)
Depression (Wellbutrin), smoking cessation (Zyban)
SE: insomnia/agitation, stimulant effects, headache, *seizures at high dose* no sedation, no addiction, no tolerance and no sexual SE no interaction with EtOH
Venlafaxine
SNRI SERT and NET blocker
Depression, anxeity, panic, PTSD
SE: Hypertension, anxeity, nausea, withdrawal symptoms, sexual dys., sedation
Trazodone
Mixed serotonin receptor and alpha 1 receptor blocker
Insomnia, High doses for depression
SE: sedation, nausea, priapism (trazo*bone*), postural hypotension
Amitriptyline
TCADs NET/SERT reuptake block
Major depression, peripheral neuropathy, chronic pain, migraine prophylaxis
SE: Sedation, antimuscarinic (Amitriptyline >Desipramine), orthostatic hypotension, Convulsions, Coma, Cardiotoxicity (arrhythmias), respiratory depression
Phenelzine
MAOI
Atypical depression, anxeity
SE: Hypertensive crisis (tyramine), CNS stimulation, Serotonin syndrome
Fluoxetine
SSRI
Block SERT
SE: Hypertension, anxeity, nausea, withdrawal symptoms (lower risk with fluox), sexual dys., sedation
Selegiline
MAOI Parkinson’s SE: Hypertensive crisis (tyramine), CNS stimulation, Serotonin syndrome
Lithium
mechanism unknown (inhibition of phosphoinositol cascade)
Mood stabilizer for bipolar blocks relapse and acute manic events
SE: narrow therapeutic index (monitoring)
LMNOP Movement (tremor) Nephrogenic Diabetes Insipitus O-hypOthyroid Pregnancy problems (Ebstein anomaly) polyuria (diabetes insipitus),
Alprazolam
Benzodiazepine agonist intensify GABA effects (binding alpha 1 and 2-5)
Increase freq. of Cl- channel opening
short acting, high potency
acute management of anxiety. (situational anxiety) ,
SE: Dependence, additive depressant effects w/ EtOH, anterograde amnesia, abuse
Flurazepam
Benzodiazepine agonist intensify GABA effects (binding alpha 1 and 2-5)
Increase freq. of Cl- channel opening
Anxiety, spasticity, detox, night terrors, sleepwalking, general anesthetic (amnesia, muscle relaxant), insomnia
SE: Dependence, additive depressant effects w/ EtOH, anterograde amnesia, abuse
Diazepam
Benzodiazepine agonist intensify GABA effects (binding alpha 1 and 2-5) Increase freq. of Cl- channel opening
longer half life
acute management of anxiety. (situational anxiety), status epileticus
SE: Dependence, additive depressant effects w/ EtOH, anterograde amnesia, abuse
Oxazepam
Benzodiazepine agonist intensify GABA effects (binding alpha 1 and 2-5)
Increase freq. of Cl- channel opening; short acting
anxiety, insomnia, withdraw from EtOH
SE: Dependence, additive depressant effects w/ EtOH, anterograde amnesia, abuse
Triazolam
Benzodiazepine agonist intensify GABA effects (binding alpha 1 and 2-5)
Increase freq. of Cl- channel opening; short acting
Insomnia
SE: Dependence, additive depressant effects w/ EtOH, anterograde amnesia, abuse
Lorazepam
Benzodiazepine agonist intensify GABA effects (binding alpha 1 and 2-5)
Increase freq. of Cl- channel opening short half life, high potency
acute management of anxiety. (situational anxiety) good for elderly, status epilepticus
SE: Dependence, additive depressant effects w/ EtOH, anterograde amnesia, abuse
Midazolam
Benzodiazepine agonist intensify GABA effects (binding alpha 1 and 2-5) Increase freq. of Cl- channel opening; short acting
anesthesia (adjunct), anxiety, insomnia
SE: Dependence, additive depressant effects w/ EtOH, anterograde amnesia, abuse
Temazepam
Benzodiazepine agonist intensify GABA effects (binding alpha 1 and 2-5) Increase freq. of Cl- channel opening
insomnia, anxiolytic, anticonvulsant, muscle relaxant
SE: Dependence, additive depressant effects w/ EtOH, anterograde amnesia, abuse
Flumazenil
Benzodiazepine receptor ANTagonist used for OD of Benzo
Zolpidem
Non-BDZ Activate BZ1 subtype of GABA receptor
Insomnia
SE: Ataxia, headache, confusion less dependence risk, less amnesia
Eszopiclone
Non-BDZ Activate BZ1 subtype of GABA receptor
Insomnia
SE: Ataxia, headache, confusion less dependence risk, less amnesia
Zaleplon
Non-BDZ Activate BZ1 subtype of GABA receptor (GABA Cl- channel)
Insomnia
SE: Ataxia, headache, confusion less dependence risk, less amnesia
Phenobarbital
Barbiturates increase *duration* of GABA CL- channel opening
Anxiety, seizures, insomnia, anesthesia (thiopental)
Seizures: partial and generalized tonic-clonic
SE: Respiratory and CV depression! Sedation!
CNS depression (worse w/ EtOH), dependence, DDI (P-450 inducer)
Ramelteon
Melatonin Receptor Agonist